Jeff, the 9th un-blinding seals the fact that Libigel is in fact SAFE!
The only questions that remain are:
1) Is it significantly safer than Placebo such that one would be compelled to file an NDA for the improvement/reduction in itself?
2) Knowing that Libigel is in fact SAFE, and after the safety data analysis is completed, will Biosante file an NDA for any of the three possible indications:
a) HSDD for naturally menopausal women,
b) As a testosterone, hormone replacement therapy product,
c) or, to alleviate menopausal symptoms, other than FSD
Market Data 
Markets 
AI
